Larotrectinib January 19, 2018 Larotrectinib Trade Name Orphan Indication Soft tissue sarcoma USA Market Approval USA USA Designation Date 2015-08-31 00:00:00 Sponsor Loxo Oncology, Inc.;281 Tresser Boulevard, 9th Floor;Stamford, Connecticut, 06901
